A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Registration Number
- NCT01071850
- Lead Sponsor
- Astellas Pharma Inc
- Brief Summary
Evaluate the efficacy, safety, and tolerability of multiple doses of ASP1941 compared to placebo over 12 weeks of therapy in adult patients with type 2 diabetes mellitus.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 412
- Subject has been diagnosed with type 2 diabetes
- Subject has a HbA1c value between 6.8 and 9.5%
- Subject has never, is not currently taking anti-diabetic medication OR is receiving a single anti- diabetic agent or low-doses two anti-diabetic medications and is willing to discontinue them during the study
- Subject is on a stable diet and exercise program
- Female subject is not pregnant and agrees to use an acceptable form of contraception throughout the duration of the study
- Subject has type 1 diabetes mellitus
- Subject is using insulin therapy
- Subject has a serum creatinine higher than upper limit of normal
- Subject has an ALT and/or AST value higher than 3 times upper limit of normal or a total bilirubin value more than 2 times upper limit of normal
- Subject has persistent, uncontrolled severe hypertension as indicated by a
systolic blood pressure >180 mmHg or a diastolic blood pressure of
>110mmHg
- Subject has had significant cardiovascular disease such as myocardial infarction or a vascular intervention (e.g., angioplasty or stent) in the last 3 months
- Subject is known to have hepatitis or be a carrier of hepatitis B surface
antigen, hepatitis C virus antibody or is known positive for HIV1 and/or
HIV2
- Subject has a history of lactic acidosis
- Subject has a history of drug and alcohol abuse/dependency within last 12
months
- Subject has had a malignancy in the last 5 years, except for successfully
treated basal or squamous cell carcinoma of the skin or of the cervix
- Subject has a symptomatic urinary tract infection or genital infection
- Female subject is lactating
- Subject has an unstable medical or psychiatric illness
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description ASP1941 lowest dose ipragliflozin oral tablet ASP1941 low dose ipragliflozin oral tablet ASP1941 high dose ipragliflozin oral tablet Placebo Placebo oral tablet ASP1941 highest dose ipragliflozin oral tablet Metformin Metformin oral tablet
- Primary Outcome Measures
Name Time Method Mean change from baseline in Hemoglobin A1c (HbA1c) 12 weeks
- Secondary Outcome Measures
Name Time Method Proportion of subjects achieving target goal of HbA1c <7.0% 12 weeks Proportion of subjects achieving target goal of HbA1c <6.5% 12 weeks Mean change from baseline in fasting plasma glucose (FPG) 12 weeks
Trial Locations
- Locations (59)
CSRA Partners in Health, Inc.
๐บ๐ธAugusta, Georgia, United States
Atlanta Vascular Research Foundation, Atlanta Cardiology & Primary Care P.C.
๐บ๐ธTucker, Georgia, United States
Bride, Bharti Hospital
๐ฎ๐ณKarnal, India
Diacon Hospital
๐ฎ๐ณBangalore, India
Cedar Crosse Research Center
๐บ๐ธChicago, Illinois, United States
Winston Technology Research, LLC
๐บ๐ธHaleyville, Alabama, United States
Desert Clinical Research
๐บ๐ธMesa, Arizona, United States
Paul W. Davis, MD, PA
๐บ๐ธPine Bluff, Arkansas, United States
Clinical Innovations, Inc.
๐บ๐ธCosta Mesa, California, United States
Expresscare Clinical Research
๐บ๐ธColorado Springs, Colorado, United States
Torrance Clinical Research
๐บ๐ธLomita, California, United States
Clinical Therapeutics Corp.
๐บ๐ธCoral Gables, Florida, United States
Del Rosario Medical Clinic, Inc
๐บ๐ธHuntington Park, California, United States
PAB Clinical Research
๐บ๐ธBrandon, Florida, United States
A.G.A Clinical Trials DBA Neostart Group
๐บ๐ธHialeah, Florida, United States
Suncoast Clinical Research
๐บ๐ธNew Port Richey, Florida, United States
APEX Medical Research, AMR, Inc
๐บ๐ธChicago, Illinois, United States
MediSphere Medical Research
๐บ๐ธEvansville, Indiana, United States
Bay West Endocrinology
๐บ๐ธTowson, Maryland, United States
Prism Research
๐บ๐ธSaint Paul, Minnesota, United States
PMG Research of Salisbury, LLC
๐บ๐ธSalisbury, North Carolina, United States
PMG Research of Charlotte, LLC
๐บ๐ธCharlotte, North Carolina, United States
Integris Family Care
๐บ๐ธYukon, Oklahoma, United States
Willamette Valley Clinical Studies
๐บ๐ธEugene, Oregon, United States
Primecare of Southeastern Ohio, Inc.
๐บ๐ธZanesville, Ohio, United States
PMG Research of Bristol, LLC
๐บ๐ธBristol, Tennessee, United States
Fleetwood Clinical Research
๐บ๐ธFleetwood, Pennsylvania, United States
Southeastern Research Associates, Inc.
๐บ๐ธTaylors, South Carolina, United States
Holston Medical Group
๐บ๐ธKingsport, Tennessee, United States
Southwind Medical Specialist
๐บ๐ธMemphis, Tennessee, United States
Corpus Christi Family Wellness Center
๐บ๐ธCorpus Christi, Texas, United States
Punzi Medical Center
๐บ๐ธCarrollton, Texas, United States
Hormone Care and Research Centre
๐ฎ๐ณGhaziabad, India
Fundacion de Caribe para le Investigacion Biomedica
๐จ๐ดBarranquilla, Colombia
School of Medicine University of Rosario
๐จ๐ดBogota, Colombia
Centro de Reumatologia y ortopedia
๐จ๐ดBarranquilla, Colombia
Aspen Clinical Research
๐บ๐ธOrem, Utah, United States
BIOMELAB
๐จ๐ดBarranquilla, Colombia
Dexa Diad Servicios Medicos
๐จ๐ดBogota, Colombia
Fundacion Cardiovascular de Columbia
๐จ๐ดFloridablanca Santander, Colombia
TOTALL Diabetes Hormone Institute Pvt.Ltd.
๐ฎ๐ณIndore, India
S R Kalla Memorial Gastro & General Hospital
๐ฎ๐ณJaipur, India
Amrita Institute of Medical Sciences and Research Centre, AIMS
๐ฎ๐ณKerala, India
Unidad Metabรณlica y Cardiovascular, SC.
๐ฒ๐ฝCuernavaca, Mexico
Instituto Jaliscience de Investigacion Clinica
๐ฒ๐ฝGuadalajara, Mexico
Torre Medica Providencia
๐ฒ๐ฝGuadalajara, Mexico
Medical Care and Research
๐ฒ๐ฝMerida, Mexico
CEDIME, Instituto Vascular
๐ฒ๐ฝMerida, Mexico
Cebu Doctors' University Hospital
๐ต๐ญCebu, Philippines
Hospital Universitario Dr. Eleuterio Gonzalez
๐ฒ๐ฝMonterrey, Mexico
St. Paul's Hospital
๐ต๐ญIloilo City, Philippines
Amang Rodriguez Memorial Medical Center
๐ต๐ญMarikina City, Philippines
San Juan De Dios Hospital
๐ต๐ญPasay City, Philippines
Parkway Medical Center
๐บ๐ธBirmingham, Alabama, United States
Central Phoenix Medical Clinic
๐บ๐ธPhoenix, Arizona, United States
San Diego Managed Care Group Clinical Research
๐บ๐ธSan Diego, California, United States
Rapid Medical Research
๐บ๐ธCleveland, Ohio, United States
Excel Clinical Research, LLC
๐บ๐ธHouston, Texas, United States
Cetero Research
๐บ๐ธSan Antonio, Texas, United States